Samtani MN - Search Results

1

Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I).

T'jollyn H, Russu A, Venkatasubramanian R, Gopal S, Nandy P, Neyens M, Faelens R, Samtani MN, Ackaert O, Perez-Ruixo JJ. T'jollyn H, et al. Among authors: samtani mn. Eur J Drug Metab Pharmacokinet. 2024 May 15. doi: 10.1007/s13318-024-00900-9. Online ahead of print. Eur J Drug Metab Pharmacokinet. 2024. PMID: 38750386

2

Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.

Galluppi GR, Ahamadi M, Bhattacharya S, Budha N, Gheyas F, Li CC, Chen Y, Dosne AG, Kristensen NR, Magee M, Samtani MN, Sinha V, Taskar K, Upreti VV, Yang J, Cook J. Galluppi GR, et al. Among authors: samtani mn. Clin Pharmacol Ther. 2024 Mar 22. doi: 10.1002/cpt.3245. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38519861 Review.

3

Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.

Miao X, Wu LS, Lin SXW, Xu Y, Chen Y, Iwaki Y, Kobos R, Stephenson T, Kemmerer K, Uhlar CM, Banerjee A, Goldberg JD, Trancucci D, Apte A, Verona R, Pei L, Desai R, Hickey K, Su Y, Ouellet D, Samtani MN, Guo Y, Garfall AL, Krishnan A, Usmani SZ, Zhou H, Girgis S. Miao X, et al. Among authors: samtani mn. Target Oncol. 2023 Sep;18(5):667-684. doi: 10.1007/s11523-023-00989-z. Epub 2023 Sep 15. Target Oncol. 2023. PMID: 37713090 Free PMC article.

4

Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose-ranging study.

Alba M, Yee J, Frustaci ME, Samtani MN, Fleck P. Alba M, et al. Among authors: samtani mn. Clin Obes. 2021 Apr;11(2):e12432. doi: 10.1111/cob.12432. Epub 2021 Jan 21. Clin Obes. 2021. PMID: 33475255 Clinical Trial.

5

Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose-ranging study.

Di Prospero NA, Yee J, Frustaci ME, Samtani MN, Alba M, Fleck P. Di Prospero NA, et al. Among authors: samtani mn. Clin Obes. 2021 Apr;11(2):e12433. doi: 10.1111/cob.12433. Epub 2021 Jan 21. Clin Obes. 2021. PMID: 33475251 Clinical Trial.

6

Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia.

Shimizu H, Neyens M, De Meulder M, Gopal S, Tsukamoto Y, Samtani MN, Remmerie B. Shimizu H, et al. Among authors: samtani mn. Clin Pharmacol Drug Dev. 2020 Feb;9(2):224-234. doi: 10.1002/cpdd.737. Epub 2019 Dec 25. Clin Pharmacol Drug Dev. 2020. PMID: 31876117 Free PMC article. Clinical Trial.

7

Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations.

Russu A, Savitz A, Mathews M, Gopal S, Feng Y, Samtani MN. Russu A, et al. Among authors: samtani mn. J Clin Psychopharmacol. 2019 Nov/Dec;39(6):567-574. doi: 10.1097/JCP.0000000000001137. J Clin Psychopharmacol. 2019. PMID: 31688450 Clinical Trial.

8

Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).

Pina LM, Dong X, Zhang L, Samtani MN, Michelson AD, Justino H, Bonnet D, Harris KC, Jefferies J, McCrindle BW, Li JS. Pina LM, et al. Among authors: samtani mn. Am Heart J. 2019 Jul;213:97-104. doi: 10.1016/j.ahj.2019.04.009. Epub 2019 May 1. Am Heart J. 2019. PMID: 31132584

9

Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, Russu A. Magnusson MO, et al. Among authors: samtani mn. CNS Drugs. 2017 Apr;31(4):273-288. doi: 10.1007/s40263-017-0416-1. CNS Drugs. 2017. PMID: 28258365 Review.

10

Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, Russu A. Magnusson MO, et al. Among authors: samtani mn. Clin Pharmacokinet. 2017 Apr;56(4):421-433. doi: 10.1007/s40262-016-0459-3. Clin Pharmacokinet. 2017. PMID: 27743205 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page